309 related articles for article (PubMed ID: 11017101)
1. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.
Cella M; Facchetti F; Lanzavecchia A; Colonna M
Nat Immunol; 2000 Oct; 1(4):305-10. PubMed ID: 11017101
[TBL] [Abstract][Full Text] [Related]
2. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production.
Bendriss-Vermare N; Burg S; Kanzler H; Chaperot L; Duhen T; de Bouteiller O; D'agostini M; Bridon JM; Durand I; Sederstrom JM; Chen W; Plumas J; Jacob MC; Liu YJ; Garrone P; Trinchieri G; Caux C; Brière F
J Leukoc Biol; 2005 Oct; 78(4):954-66. PubMed ID: 16081597
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.
Cella M; Jarrossay D; Facchetti F; Alebardi O; Nakajima H; Lanzavecchia A; Colonna M
Nat Med; 1999 Aug; 5(8):919-23. PubMed ID: 10426316
[TBL] [Abstract][Full Text] [Related]
4. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
5. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.
Ito T; Yang M; Wang YH; Lande R; Gregorio J; Perng OA; Qin XF; Liu YJ; Gilliet M
J Exp Med; 2007 Jan; 204(1):105-15. PubMed ID: 17200410
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.
Yoneyama H; Matsuno K; Toda E; Nishiwaki T; Matsuo N; Nakano A; Narumi S; Lu B; Gerard C; Ishikawa S; Matsushima K
J Exp Med; 2005 Aug; 202(3):425-35. PubMed ID: 16061729
[TBL] [Abstract][Full Text] [Related]
8. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts.
Chaperot L; Perrot I; Jacob MC; Blanchard D; Salaun V; Deneys V; Lebecque S; Brière F; Bensa JC; Plumas J
Eur J Immunol; 2004 Feb; 34(2):418-26. PubMed ID: 14768046
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th1-type immune response.
Flohé SB; Agrawal H; Schmitz D; Gertz M; Flohé S; Schade FU
J Leukoc Biol; 2006 Mar; 79(3):473-81. PubMed ID: 16365154
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells.
Son Y; Ito T; Ozaki Y; Tanijiri T; Yokoi T; Nakamura K; Takebayashi M; Amakawa R; Fukuhara S
Immunology; 2006 Sep; 119(1):36-42. PubMed ID: 16762028
[TBL] [Abstract][Full Text] [Related]
12. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
[TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.
Farkas L; Kvale EO; Johansen FE; Jahnsen FL; Lund-Johansen F
J Allergy Clin Immunol; 2004 Aug; 114(2):436-43. PubMed ID: 15316529
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
16. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.
Novak N; Allam JP; Hagemann T; Jenneck C; Laffer S; Valenta R; Kochan J; Bieber T
J Allergy Clin Immunol; 2004 Aug; 114(2):364-70. PubMed ID: 15316517
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs.
Schneider K; Meyer-Koenig U; Hufert FT
PLoS One; 2008; 3(10):e3482. PubMed ID: 18941519
[TBL] [Abstract][Full Text] [Related]
18. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
[TBL] [Abstract][Full Text] [Related]
20. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
